Steven H. Holtzman

2010 - Infinity Pharmaceuticals

In 2010, Steven H. Holtzman earned a total compensation of $2.3M as Executive Chair at Infinity Pharmaceuticals, a 123% increase compared to previous year.

Compensation breakdown

Bonus$400,000
Non-Equity Incentive Plan$247,000
Option Awards$548,075
Salary$520,000
Stock Awards$588,000
Other$7,782
Total$2,310,857

Holtzman received $588K in stock awards, accounting for 25% of the total pay in 2010.

Holtzman also received $400K in bonus, $247K in non-equity incentive plan, $548.1K in option awards, $520K in salary and $7.8K in other compensation.

Rankings

In 2010, Steven H. Holtzman's compensation ranked 2,650th out of 10,439 executives tracked by ExecPay. In other words, Holtzman earned more than 74.6% of executives.

ClassificationRankingPercentile
All
2,650
out of 10,439
75th
Division
Manufacturing
920
out of 3,838
76th
Major group
Chemicals And Allied Products
183
out of 921
80th
Industry group
Drugs
97
out of 680
86th
Industry
Pharmaceutical Preparations
78
out of 481
84th
Source: SEC filing on April 11, 2011.

Holtzman's colleagues

We found four more compensation records of executives who worked with Steven H. Holtzman at Infinity Pharmaceuticals in 2010.

2010

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2010

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2010

Julian Adams

Infinity Pharmaceuticals

President of R&D

2010

Pedro Santabarbara

Infinity Pharmaceuticals

Chief Medical Officer

You may also like